All News

Understanding Recent Developments in Mantle Cell Lymphoma

November 23, 2022

In an interview with Targeted Oncology, Jia Ruan, MD, PhD, discussed the updates in the mantle cell lymphoma space, including understanding molecular pathogenesis and risk stratification for this patient population.

CD19-/CD22-CAR T Cells Elicits Durable Remissions in Children With R/R B-Cell ALL

November 22, 2022

In pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia, complete remissions were achieved in 99.0% of patients and their overall 12-month event-free survival was 73.5% with CD19-/CD22-chimeric antigen receptor therapy.

Pembrolizumab Combo Prolongs Survival in HER2–, Locally Advanced Unresectable or Metastatic Gastric/GEJ Cancers

November 22, 2022

Results from the phase 3 KEYNOTE-859 study show extended overall and progression-free survival in patients with HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal adenocarcinoma treated with pembrolizumab and chemotherapy.